Start Date
Immediate
Expiry Date
21 Dec, 26
Salary
75000.0
Posted On
22 Sep, 26
Experience
18 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Industry
Healthcare & Life Sciences
Vertanical – A World Free of Chronic Pain. We are a leading global biopharmaceutical company specializing in the development and distribution of innovative medicines for the treatment of chronic pain. Our vision is clear: a world free of chronic pain! With VER-01, we have developed a unique cannabinoid-based medicine for the treatment of chronic pain, which was approved in Germany and Austria in June 2026 under the name Exilby. This marks a significant milestone after more than eight years of intensive research and development.
Approval in the USA is planned for 2029. Our goal is to establish Exilby as the leading therapy for the treatment of chronic pain by 2030, setting new standards in pain management. Does
this sound exciting to you? Then apply now! We look forward to getting to know you.
Shape the future of pain therapy with us! As a driving force behind groundbreaking clinical trials, you'll not only be responsible for planning, budget, and management, but also lead a dedicated team of experts to success. In this key role, you'll be the engine of innovation, ensuring that our vision of a pain-free world becomes a reality. Are you ready to rethink processes and take studies to the next level? Then we're looking for you!
We get things done – and fast! You can expect a top management board comprised of high-caliber entrepreneurs, former consultants, and experienced industry leaders. We offer you an environment where you can develop personally and professionally in an unparalleled way.
Do you have any questions?
Please contact your designated contact person directly:
FUTRUE GmbH
[RECRUITER]
Am Haag 14
82166 Gräfelfing
Apply now! We look forward to getting to know you.
*For the sake of readability, the masculine form is used in this advertisement. It explicitly refers to all genders (f/m/d).
Vertanical – A World Free of Chronic Pain. We are a leading global biopharmaceutical company specializing in the development and distribution of innovative medicines for the treatment of chronic pain. Our vision is clear: a world free of chronic pain! With VER-01, we have developed a unique cannabinoid-based medicine for the treatment of chronic pain, which was approved in Germany and Austria in June 2026 under the name Exilby. This marks a significant milestone after more than eight years of intensive research and development.
Approval in the USA is planned for 2029. Our goal is to establish Exilby as the leading therapy for the treatment of chronic pain by 2030, setting new standards in pain management. Does
this sound exciting to you? Then apply now! We look forward to getting to know you.
Shape the future of pain therapy with us! As a driving force behind groundbreaking clinical trials, you'll not only be responsible for planning, budget, and management, but also lead a dedicated team of experts to success. In this key role, you'll be the engine of innovation, ensuring that our vision of a pain-free world becomes a reality. Are you ready to rethink processes and take studies to the next level? Then we're looking for you!
We get things done – and fast! You can expect a top management board comprised of high-caliber entrepreneurs, former consultants, and experienced industry leaders. We offer you an environment where you can develop personally and professionally in an unparalleled way.
Do you have any questions?
Please contact your designated contact person directly:
FUTRUE GmbH
[RECRUITER]
Am Haag 14
82166 Gräfelfing
Apply now! We look forward to getting to know you.
*For the sake of readability, the masculine form is used in this advertisement. It explicitly refers to all genders (f/m/d).